- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01744990
Tree Nuts Allergies: Does a Single Nut Allergy Necessitate the Dietary Eviction of Other Tree Nuts? (ProNut)
Tree Nuts Allergies: Does a Single Nut Allergy Necessitate the Dietary Eviction?
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Food allergy in children is a disease of growing importance, current estimation in school age children are between 4 and 8 %. The most frequently involved foods in IgE reaction in school-aged children are hazelnut (especially in Switzerland according to the ongoing Swiss Registry, Wiesner et al, personal communication) and peanut. Tree nuts and peanut allergies are often involved in severe reactions, including cases of death by anaphylaxis. In addition, the disease is long-lasting as Fleischer et al could show that only 9% of children with nut allergies will outgrew from it. This number is worse than for peanut where a positive outcome is seen in 20% of the patients.
Food challenges are the most reliable tests to investigate a possible food allergy, but these are time consuming and may elicit severe reactions in patients with a previous history of anaphylactic reactions(8). There are no allergy tests able at this time to predict with certainty the clinical reactivity, although Sampson et al could identify a general tree nuts specific IgE cut-off level with a high positive predictive value for clinical reactivity.
It could be demonstrated, in well-designed studies, that in vitro cross-sensitivity between tree nuts (members of the oleaginous family) and peanut (members of the legume family) is frequent (86%). However, clinical reactions to tree nuts are estimated to be present in only 40% of peanut allergic patients. Therefore 60% of peanut allergic patients may eat tree nuts without reactions.
Similarly, there is a large in vitro cross-sensitivity between tree nuts. However, it is not known to date if this cross-sensitivity relates to clinical reactivity. Consequently, in case of one tree nut allergy, strict eviction to all nuts is largely recommended, and possibly results in a unnecessary dietary eviction of all tree nuts leading to a high impact on the quality of life of the children.
We aim to identify, based on standardized food provocation tests, which nuts allergic patients need a selective, or a complete dietary eviction of all kind of nuts (nuts being defined as peanut, all tree nuts, pine nut and sesame). We postulate that predictive factors of multiple nut allergy are high specific immunoglobulin E level, positive skin tests and/or clinical markers, such as atopic dermatitis, presence of other food allergies or a history of a severe previous reaction.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Valencia, Spain, 46009
- Hospital Infantil La Fe
-
-
-
-
GE
-
Geneva, GE, Switzerland, 1211
- University Hospital Geneva
-
-
-
-
-
London, United Kingdom, SE1 7EH
- St. Thomas' Hospital
-
-
Surrey
-
Chertsey, Surrey, United Kingdom, KT16 0PZ
- St. Peter's Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Children 1 - 16 years of age at the time of inclusion (a minimum of 75 children < 6 years old required, over the 3 centers)
- Children with convincing history of IgE-mediated systemic allergic reaction (not only oral symptoms) after consumption of one or more "nuts" (peanut, hazelnut, walnut, almond, cashew, pecan, Brazil, macadamia, pine nut, sesame) within last 12 months and SPT > 3 mm and/or positive specific IgE (>0.1 kU/l).
- Children without a convincing history of IgE-mediated systemic allergic reaction (for example only oral symptoms) after consumption of one or more "nuts" (peanut, hazelnut, walnut, almond, cashew, pecan, brazil, macadamia, pistachio, pine nut, sesame) but with clear evidence of sensitization (SPT > 3 mm and/or positive specific IgE (> 0.1 kU/l) and a positive standardized food challenge to the nut.
- Informed consent approved and signed by the patient's legal representative and, if applicable, by the child itself.
Exclusion Criteria:
- Uncontrolled asthma (according to the European Guidelines)(13)
- Chronic urticaria
- Children with a chronic systemic disease
- Children who are dependent on daily antihistamine use
Study Plan
How is the study designed?
Design Details
- Primary Purpose: DIAGNOSTIC
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
OTHER: Interventional single arm
Single group of children undergoing the same investigations and follow up
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Evaluation of cross reactivity in nut allergic children
Time Frame: 12 months
|
With the aim of oral food challenges (OFC's)in nut allergic children, we want to study the allergic cross-reactivity of all nut.
The efficiency of various allergological testing, like skin prick tests, specific IgE or basophil activation test in predicting the potential cross-reactivity versus oral tolerance will be assessed.
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Identify predictive factors of multiple nut allergy
Time Frame: 12 months
|
We postulate that predictive factors of multiple nut allergy are high specific IgE level, positive skin tests and/or clinical markers, such as atopic dermatitis, presence of other food allergies or a history of a severe previous reaction.
|
12 months
|
|
Quality of life in food allergic children
Time Frame: 36 months
|
Studying variation of quality of life after reintroduction of various nuts with a validated food allergy of life questionnaire (FAQLQ).
filled up by the parents and/or the child during follow uip visits
|
36 months
|
|
Follow up visits to evaluate the uprising of an allergy to a nut regularly ingested
Time Frame: 36 months
|
With the aim of follow up visits during a total of 36 months, will want to evaluate the consumption of tolerated or reintroduced nuts.
The goal is to analyze the risk an nut allergic child might present a new allergy to an other nut he is regularly consuming.
|
36 months
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Philippe A Eigenmann, MD, University Hospital, Geneva
- Study Chair: Gideon Lack, MD, St. Thomas' Hospital, London (UK)
- Study Chair: Antonio Nieto, MD, Hospital Infantil La Fe, Valencia, Spain
- Principal Investigator: Helen Brough, MD, St. Thomas' Hospital, London (UK)
- Principal Investigator: Haddad Diab, MD, St. Peter's Hospital, Surrey (UK)
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CER12-020
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Nut Allergy in Children
-
King's College LondonGuy's and St Thomas' NHS Foundation TrustUnknownEgg Allergy | Food Allergy | Food Allergy in Children | Milk Allergy | Food Allergy in Infants | Nut Allergy | Food Allergen SensitisationUnited Kingdom
-
King's College LondonKing's College Hospital NHS Trust; University College London Hospitals; Cambridge... and other collaboratorsRecruitingEgg Allergy | Food Allergy | Food Allergy in Children | Milk Allergy | Food Allergy in Infants | Nut Allergy | Food Allergen SensitisationUnited Kingdom
-
Luxembourg Institute of HealthCentre Hospitalier du LuxembourgActive, not recruitingAllergy;Food | Food Allergy | Food Allergy in Children | Food Allergy Peanut | Tree Nut Allergies | Oral Immunotherapy for Food AllergyLuxembourg
-
Chinese University of Hong KongActive, not recruitingPeanut Allergy | Food Allergy in ChildrenHong Kong
-
Chinese University of Hong KongRecruiting
-
Murdoch Childrens Research InstituteCompletedFood Allergy in Infants | Nut AllergyAustralia
-
Gordon Sussman Clinical ResearchMast Cell Pharmaceuticals Inc.UnknownPeanut Allergies in ChildrenCanada
-
University of RochesterNational Institute of Allergy and Infectious Diseases (NIAID)RecruitingEgg Allergy | Food Allergy Peanut | Food Allergy in Infants | Allergy and Immunology | Peanut and Nut AllergyUnited States
-
Boston Children's HospitalNot yet recruiting
-
HUS Skin and Allergy HospitalRecruitingTree Nut Allergy | Oral Immunotherapy for Food Allergy | Cashew Nut AllergyFinland
Clinical Trials on Oral food challenges to multiple nuts
-
University Hospital, GenevaTerminatedPeanut Allergy | Food Allergy | Tree Nut AllergySwitzerland
-
DR. MALA KHANBangladesh Reference Institute of Chemical Measurements (BRICM)CompletedEfficacy, Self | Effect of Drug | Virus Infection, RNABangladesh
-
Suleyman Demirel UniversityCompletedOral Findings in Children of Multiple and Single Births | Radiographic Evaluation of Oral Findings in Children of Multiple and Single BirthsTurkey
-
Tanta UniversityRecruitingIdiopathic Scoliosis | Posterior Spinal Fusion | PCA | Multiple Mid-Transverse Process to PleuraEgypt
-
Jaeb Center for Health ResearchActive, not recruitingCystic FibrosisUnited States